Physician profile
Daniel Milgrom
NPI 1710326137
$3,751.69
in general payments reported to CMS, 2019-2025
6 companies · $2,321 in 2025
The $2,321 reported for 2025 was more than what 84% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $408 · 2021: $471 · 2024: $363 · 2025: $2,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $875 · Travel and Lodging: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $874.65 |
| Travel and Lodging | $809.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,184.98 | 2021-2025 | |
| Tela Bio, INC. | $775.08 | 2019-2021 | |
| Dilon Technologies, INC. | $407.34 | 2025 | Hemoblast Bellows |
| Angiodynamics, INC. | $220.11 | 2024-2025 | Nanoknife |
| Abbvie INC. | $112.20 | 2024 | |
| Davol INC. | $51.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Milgrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.